Intro to COVID-19: Diagnostics and Laboratory Testing
This session will cover emerging issues in diagnostics and laboratory testing, including emergency use authorization declarations for diagnostics, overview of testing types, and enforcement and PREP Act immunity.
Beth P. Weinman, Counsel, Ropes & Gray LLP
This session was recorded as part of FDLI’s virtual course, “COVID-19: Introduction to FDA’s Existing Legal Authorities and Emerging Issues” on August 19, 2020.
- +$100 for nonmembers
Legal issues regarding the response to COVID-19 is a rapidly evolving field. It is important to note the program recording date given that FDA guidance may have revised or been updated. For questions, please check the FDA website at: https://www.fda.gov/home
Virtual Learning FAQ